Article Information
History
- March 6, 2022.
Article Versions
- Version 1 (November 11, 2021 - 09:43).
- Version 2 (December 2, 2021 - 08:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Juliet R.C. Pulliam1,*,
- Cari van Schalkwyk1,
- Nevashan Govender2,
- Anne von Gottberg2,3,
- Cheryl Cohen2,4,
- Michelle J. Groome2,3,
- Jonathan Dushoff1,5,
- Koleka Mlisana6,7,8 and
- Harry Moultrie2,3
- 1South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa
- 2National Institute for Communicable Diseases, Division of the National Health Laboratory Service, South Africa
- 3School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 4School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 5McMaster University, Canada
- 6National Health Laboratory Service, South Africa
- 7School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, South Africa
- 8Centre for the AIDS Programme of Research in South Africa (CAPRISA), South Africa
- ↵*corresponding author: pulliam{at}sun.ac.za
Posted March 06, 2022.
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
